Guardant Health Raises $360M in Series E
Guardant Health has successfully raised $360M in a Series E at a $2.15B valuation led by SoftBank Vision Fund, OrbiMed.
Company Overview
Guardant Health is a Biotech company headquartered in Redwood City, CA, founded in 2012 with 1000+ employees.
Blood-based cancer detection and monitoring
Fundraising Details
- Amount Raised: $360M
- Round Type: Series E
- Valuation: $2.15B
- Date: 2018-05-31
- Investors: SoftBank Vision Fund, OrbiMed
About Guardant Health
Blood-based cancer detection and monitoring The company is positioned in the Biotech sector, serving a growing market with innovative solutions.
Key Information
- Headquarters: Redwood City, CA
- Founded: 2012
- Team Size: 1000+
- Industry: Biotech
What This Means
This funding round demonstrates strong investor confidence in Guardant Health's vision and execution. The capital will likely be used to:
- Scale Operations: Expand the team and operational capacity
- Product Development: Enhance existing products and develop new features
- Market Expansion: Enter new markets and strengthen presence in existing ones
- Technology Investment: Invest in infrastructure and technology capabilities
Industry Context
The Biotech sector continues to attract significant investment as companies innovate to meet evolving market demands. Guardant Health's successful fundraising reflects the strong fundamentals and growth potential in this space.
Valuation Milestone
Reaching a $2.15B valuation marks an important milestone for Guardant Health, positioning the company among notable players in the Biotech industry.
Looking Ahead
With this new capital, Guardant Health is well-positioned to execute on its growth strategy and continue building innovative solutions in the Biotech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.
---
This fundraising news was reported on 2018-05-31. For more information about Guardant Health, visit their headquarters at Redwood City, CA.
